Crystalline (-)-6- chloro-4- cyclopropylethynyl- 4-trifluoromethyl- 3,4-dihydro- 2(1h)-quinazolinone
CA 2345516 A1 · Owner: Parsons, Rodney Lawrence Jr. · Inventors: Parsons, Rodney Lawrence Jr.; Patel, Mona; Rabel, Shelley R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The potent reverse transcriptase inhibitor (-)-6-Chloro-4-cyclopropylethynyl-4trifluoromethyl-3,4-dihydro-2(1H)-quinazolinone is produced in solvate and crystalline form. These forms are designated Forms 1 and 2 and are , characterized by x-ray powder diffraction and differential scanning calorimetry. Pharmaceutical compositions and methods are useful for the treatment of the human immunodeficiency virus (HIV).
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 18, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 18, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 18, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.